Skip to main content
Wiley Open Access Collection logoLink to Wiley Open Access Collection
. 2021 May 1;178(10):2161. doi: 10.1111/bph.15449

Correction

PMCID: PMC9394607  PMID: 33932231

In the paper “The anti‐parasitic drug miltefosine suppresses human eosinophil activation and ameliorates murine allergic inflammation in vivo” by Knuplez et al, the title has been amended to “The anti‐parasitic drug miltefosine suppresses activation of human eosinophils and ameliorates allergic inflammation in mice.”

REFERENCE

  1. Knuplez, E. , Kienzl, M. , Trakaki, A. , Schicho, R. , Heinemann, A. , Sturm, E. M. , & Marsche, G. (2021). The anti‐parasitic drug miltefosine suppresses activation of human eosinophils and ameliorates allergic inflammation in mice. British Journal of Pharmacology, 178, 1234–1248. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of Wiley

RESOURCES